Tag: Takeda to present data from the ICLUSIG (ponatinib) Clinical Trial Program that Could Prove Practice-Changing for the Treatment of Chronic-Phase CML
Most Read
FeaturedHeineken Lokpobiri’s statement about NCDMB is reckless, bundle of lies – WaboteBy editor5 MIN READ
Subscribe to Our Newsletter
Keep abreast of news and other developments from our website.